Literature DB >> 30320502

ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later

Henry B Burch1, David S Cooper2.   

Abstract

The thionamide antithyroid drugs were discovered in large part following serendipitous observations by a number of investigators in the 1940s who found that sulfhydryl-containing compounds were goitrogenic in animals. This prompted Prof. Edwin B Astwood to pioneer the use of these compounds to treat hyperthyroidism in the early 1940s and to develop the more potent and less toxic drugs that are used today. Despite their simple molecular structure and ease of use, many uncertainties remain, including their mechanism(s) of action, clinical role, optimal use in pregnancy and the prediction and prevention of rare but potentially life-threatening adverse reactions. In this review, we summarize the history of the development of these drugs and outline their current role in the clinical management of patients with hyperthyroidism.
© 2018 European Society of Endocrinology

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30320502     DOI: 10.1530/EJE-18-0678

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

1.  Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.

Authors:  L H Duntas
Journal:  J Endocrinol Invest       Date:  2020-09-30       Impact factor: 4.256

2.  Comparison of 99mTc Pertechnetate Thyroid Uptake Rates by Gamma Probe and Gamma Camera Methods for Differentiating Graves' Disease and Thyroiditis.

Authors:  Meihua Jin; Jonghwa Ahn; Seong-Gil Jo; Jangwon Park; Min Ji Jeon; Won Gu Kim; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jin-Sook Ryu
Journal:  Nucl Med Mol Imaging       Date:  2022-01-07

Review 3.  2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.

Authors:  Thanh D Hoang; Derek J Stocker; Eva L Chou; Henry B Burch
Journal:  Endocrinol Metab Clin North Am       Date:  2022-05-11       Impact factor: 4.748

4.  Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves' Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method.

Authors:  Verena Theiler-Schwetz; Thomas Benninger; Christian Trummer; Stefan Pilz; Markus Reichhartinger
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

Review 5.  Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.

Authors:  M Tonacchera; L Chiovato; L Bartalena; A F Cavaliere; P Vitti
Journal:  J Endocrinol Invest       Date:  2019-11-29       Impact factor: 4.256

Review 6.  Hyperthyroidism.

Authors:  Amanda R Doubleday; Rebecca S Sippel
Journal:  Gland Surg       Date:  2020-02

Review 7.  Antithyroid drugs and birth defects.

Authors:  Stine Linding Andersen; Stig Andersen
Journal:  Thyroid Res       Date:  2020-06-27

Review 8.  Graves' Disease: Can It Be Cured?

Authors:  Wilmar M Wiersinga
Journal:  Endocrinol Metab (Seoul)       Date:  2019-03

9.  Practice patterns and outcomes in the management of Thai patients with Graves' disease.

Authors:  Yotsapon Thewjitcharoen; Krittadhee Karndumri; Waralee Chatchomchuan; Sriurai Porramatikul; Sirinate Krittiyawong; Ekgaluck Wanathayanoroj; Nampetch Lekpittaya; Worawit Kittipoom; Tawee Anuntakulnatee; Somboon Vongterapak; Siriwan Butadej; Soontaree Nakasatien; Rajata Rajatanavin; Thep Himathongkam
Journal:  Thyroid Res       Date:  2021-03-03

10.  A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression.

Authors:  Tien-Yuan Wu; Chung-Hsing Wang; Ni Tien; Cheng-Li Lin; Fang-Yi Chu; Hsiao-Yun Chang; Yun-Ping Lim
Journal:  Front Med (Lausanne)       Date:  2020-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.